Affinity hemosorbent for the binding of atherogenic lipoproteins
Lopukhin, I.M.; Andrianova, I.P.; Rabovskiĭ, A.B.; Nalivaĭko, E.S.; Kulaev, D.V.
Kardiologiia 26(10): 54-57
1986
ISSN/ISBN: 0022-9040 PMID: 3795705 Document Number: 276568
An affine hemosorbent, a product of covalent heparin immobilization on a solid matrix, has been proposed for the extraction of atherogenic lipoproteins. The sorbent has high capacity with respect to atherogenic lipoproteins and is selective with other blood constituents. Experimental hemosorption in animals demonstrated rapid sorbent regeneration and satisfactory hemo- and biocompatibility, therefore the new sorbent can be recommended for clinical application.
Document emailed within 1 workday
Related Documents
Mertz, D.P.; Göhmann, E.; Ostertag, J. 1981: Differential use of apolipoproteins and lipoproteins as discriminators for atherogenic risk Die Medizinische Welt 32(43): 1611-1615Chamberlain, J.; Offord, S.J.; Wolfe, B.B.; Tyau, L.S.; Wang, H.L.; Frazer, A. 1993: Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding Journal of Pharmacology and Experimental Therapeutics 266(2): 618-625
Mahley, R.W.; Weisgraber, K.H.; Innerarity, T.L.; Rall, S.C. 1991: Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolism JAMA 265(1): 78-83
Riesen, W.F.; Descoeudres, C.; Mordasini, R.; Girod, M.A. 1989: Selective elimination of atherogenic lipoproteins using dextran-sulfate cellulose. Experiences in 2 patients with heterozygote familial hypercholesterolemia Schweizerische Medizinische Wochenschrift 119(2): 55-58
Vasil'chenko, E.M.; Beĭko, V.A.; Tymchishin, P.N.; Karpov, R.S. 1989: Changes in the rosette-forming capacity of peripheral blood lymphocytes in patients with ischemic heart disease after administration of atherogenic lipoproteins Kardiologiia 29(2): 53-56
Muto, Y.; Moriwaki, H.; Omori, M. 1981: In vitro binding affinity of novel synthetic polyprenoids (polyprenoic acids) to cellular retinoid-binding proteins Gan 72(6): 974-977
Urien, S.; Morin, D.; Rocher, I.; Tillement, J.P. 1989: Tertatolol high affinity binding to alpha 1-acid glycoprotein: stereospecificity and consequences on plasma binding in disease states Progress in Clinical and Biological Research 300: 453-456
Vasil'chenko, E.M.; Beĭko, V.A.; Karpov, R.S.; Kanskaia, N.V. 1989: Characteristics of the action of modified atherogenic-class lipoproteins on the functional activity of peripheral blood lymphocytes in patients with ischemic heart disease Terapevticheskii Arkhiv 61(9): 56-59
Choudhary, M.S.; Sachs, N.; Uluer, A.; Glennon, R.A.; Westkaemper, R.B.; Roth, B.L. 1995: Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding Molecular Pharmacology 47(3): 450-457
Rothman, R.B.; Bowen, W.D.; Herkenham, M.; Jacobson, A.E.; Rice, K.C.; Pert, C.B. 1985: A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site Molecular Pharmacology 27(3): 399-409
Green, P.J.; Tamatani, T.; Watanabe, T.; Miyasaka, M.; Hasegawa, A.; Kiso, M.; Yuen, C.T.; Stoll, M.S.; Feizi, T. 1992: High affinity binding of the leucocyte adhesion molecule L-selectin to 3'-sulphated-Le(a) and -Le(x) oligosaccharides and the predominance of sulphate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharides Biochemical and Biophysical Research Communications 188(1): 244-251
Ogunro, P.S.; Ologunagba, P.O. 2012: Plasma level of atherogenic and anti-atherogenic factors among palm wine drinkers of rural southwest Nigeria African Journal of Medicine and Medical Sciences 41(4): 337-347
Nurakawa, T.; Nishida, M. 1970: Binding of penicillins with serum protein. 3. Relationship between protein-binding of penicillins and other antibiotics and gel affinity Japanese Journal of Antibiotics 23(3): 223-227
Ren, L.; Chen, H.; Sternberg, E.A. 1994: Tethered bandshift assay and affinity purification of a new DNA-binding protein Biotechniques 16(5): 852-855
Barbin, G.; Palacios, J.M.; Rodergas, E.; Schwartz, J.C.; Garbarg, M. 1980: Characterization of the high-affinity binding sites of [3H]histamine in rat brain Molecular Pharmacology 18(1): 1-10
Karulin, A.I.; Dikov, M.M.; Egorov, A.M. 1986: Determination of binding constants of antibodies fractionated according to their affinity to insulin Biokhimiia 51(5): 746-750
Lukas, R.J. 1990: Heterogeneity of high-affinity nicotinic [3H]acetylcholine binding sites Journal of Pharmacology and Experimental Therapeutics 253(1): 51-57
Menzel, E.J.; Kolarz, G. 1990: Binding affinity of ibuprofen to collagen and other connective tissue components Arzneimittel-Forschung 40(4): 481-483
Stämpfli, M.R.; Rudolf, M.; Miescher, S.; Pachlopnik, J.M.; Stadler, B.M. 1995: Antigen-specific inhibition of IgE binding to the high-affinity receptor Journal of Immunology 155(6): 2948-2954
Hesz, A.; Robenek, H.; Ingolic, E.; Roscher, A.; Krempler, F.; Sandhofer, F.; Kostner, G.M. 1985: Demonstration of receptor binding of two apo-B containing lipoproteins by differential labelling with colloidal gold European Journal of Cell Biology 37: 229-233